RECENT POSTS
Archives
- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Protein-Driven Cell Reprogramming
The latest in cell reprogramming research is that scientists at the Scripps Research Institute in La Jolla, California have created induced cells into an embryonic state using proteins instead of genes. The study involves mouse cells.
The process, reported in Cell Stem Cell, points towards a method of creating pluripotent cells without the significant risk of tumor growth that original techniques created.
The Wall Street Journal indicates that “a race is on to commercialize the technique,” as an author of the study, Sheng Ding, is the founder of a biotech startup aiming to provide tissue created through a reprogramming process to drug development companies.
Comments on this article
